These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 113022)

  • 21. [Anti-angina and hemodynamic action of labetalol in angina patients].
    Sharaeva ML
    Vrach Delo; 1987 May; (5):57-9. PubMed ID: 3617687
    [No Abstract]   [Full Text] [Related]  

  • 22. Sustained effects of transdermal nitroglycerin in patients with angina pectoris.
    Kapoor AS; Dang NS; Reynolds RD
    Clin Ther; 1985; 7(6):674-9. PubMed ID: 3935313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative characteristics of the hemodynamic and antianginal actions of obzidan and albetol in patients with stenocardia].
    Zaĭtseva VI; Sharaeva ML
    Vrach Delo; 1988 Dec; (12):15-8. PubMed ID: 2907700
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of the alpha and beta blocking effects of intravenous labetalol on left ventricular function in coronary artery disease.
    Gagnon RM; Presant S; Morissette M
    Can J Cardiol; 1985; 1(4):259-62. PubMed ID: 2996729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verapamil in chronic stable angina: a controlled study with computerized multistage treadmill exercise.
    Bala Subramanian V; Lahiri A; Parmasivan R; Raftery EB
    Clin Invest Med; 1980; 3(1-2):111-8. PubMed ID: 6781805
    [No Abstract]   [Full Text] [Related]  

  • 26. Tiapamil dose ranging study on exercise performance in patients with exercise induced angina and coronary artery disease.
    Maltz MB; O'Keefe JC; Butrous GS; Camm AJ
    Arq Bras Cardiol; 1984 Jun; 42(6):443-6. PubMed ID: 6393922
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
    Dorow P; Schiess W
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Morgan JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4990005
    [No Abstract]   [Full Text] [Related]  

  • 29. Nitroderm TTS in exercise-induced angina pectoris--a randomized double-blind study.
    Colombo G; Favini G; Aglieri S; Pollavini G; de Vita C
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):211-4. PubMed ID: 3922903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris.
    Jonker JJ; de Klerk J; den Ottolander GJ
    Arzneimittelforschung; 1981; 31(7):1140-2. PubMed ID: 6115654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Verapamil in the treatment of angina pectoris. Double-blind study with clinical and ergometric evaluation].
    de Brito FS; Pereira MH
    Arq Bras Cardiol; 1979 Jun; 32(6):415-21. PubMed ID: 389213
    [No Abstract]   [Full Text] [Related]  

  • 32. Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study.
    Frishman WH; Shapiro W; Charlap S
    J Clin Pharmacol; 1989 Jun; 29(6):504-11. PubMed ID: 2666451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labetalol and alprenolol. A comparative investigation of antihypertensive effect.
    Kofod P; Kjaer K; Vejlø S; Hvidt S
    Postgrad Med J; 1980; 56 Suppl 2():69-74. PubMed ID: 7001423
    [No Abstract]   [Full Text] [Related]  

  • 34. [Labetalol--ergometric and polycardiographic studies].
    Dziekański S; Adamska-Dyniewska H; Słomka S; Tkaczewski W
    Wiad Lek; 1984 Mar; 37(5):334-41. PubMed ID: 6475046
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of a sustained-release buccal nitroglycerin preparation in stable angina pectoris.
    Grasso S; Pesciatini F; Ugolini C; Lepore R; Cerri B
    Int J Clin Pharmacol Res; 1988; 8(2):131-7. PubMed ID: 3132428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P; Pessina AC; Sperti G; Ventura E; Agnoletto V; Semplicini A; Hlede M; Gava R; Mormino P; Dal Palù C
    G Ital Cardiol; 1983; 13(1):18-22. PubMed ID: 6873535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of labetalol and chlorthalidone on exercise tolerance in hypertensive subjects].
    Raffo M; Cherchi A; Sau F; Pirisi R; Seguro C; Pisano MR
    Boll Soc Ital Cardiol; 1979; 24(6):657-66. PubMed ID: 551798
    [No Abstract]   [Full Text] [Related]  

  • 40. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.